Toth Financial Advisory Corp Lyra Therapeutics, Inc. Transaction History

Toth Financial Advisory Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$6.06 - $9.43 $303 - $471	-50 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$6.91 - $12.59 $345 - $629	-50 Reduced 50.0%	50 $0
Q1 2021 Apr 20, 2021	BUY	$10.38 - $15.61 $1,038 - $1,561	100 New	100 $1,000

32M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.05M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.